GliaPharm SA

Swiss Biotech Association

Not a member

GliaPharm is a Swiss biotechnology company developing treatments for orphan neurological disorders. The company has developed a proprietary platform and pipeline of molecules targeting brain glial cells to restore brain metabolism deficits in orphan diseases linked to brain metabolism dysfunction.

http://www.gliapharm.com

Location

Chemin des Mines 9, Geneva, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2016
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Sintetica SA

Sintetica is a pharmaceutical company delivering injectable medicines to patients worldwide, through innovative science and excellence in development, production and marketing. The multicultural high-performing organization is built to support both the national growth and the global expansion.
Mendrisio

Member

Labatec Pharma SA

Labatec is a privately owned Swiss-based pharmaceutical company with more than 50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.
Meyrin

Member

GlycoEra AG

GlycoEra leverages its control over natural glycan-mediated pathways to advance novel drugs using its propriety platform, the CustumGlycan Platform. GlycoEra develops first in class therapeutics in inflammatory disease, autoimmune disorder and immuno-oncology indications.
8952 Schlieren

Member